HYO

[(1S,5R)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] (2S)-3-hydroxy-2-phenylpropanoate

Created:	2020-01-02
Last modified:	2020-03-18

Find Related PDB Entry
6 entries where HYO is found as a standalone ligand

Help Find related ligands:
Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Help

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	44
Chiral Atom Count	4
Bond Count	46
Aromatic Bond Count	6

WebGL does not seem to be available.

This can be caused by an outdated browser, graphics card driver issue, or bad weather. Sometimes, just restarting the browser helps. Also, make sure hardware acceleration is enabled in your browser.

For a list of supported browsers, refer to http://caniuse.com/#feat=webgl.

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	[(1S,5R)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] (2S)-3-hydroxy-2-phenylpropanoate
Systematic Name (OpenEye OEToolkits)	[(1~{R},5~{S})-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] (2~{S})-3-oxidanyl-2-phenyl-propanoate
Formula	C₁₇ H₂₃ N O₃
Molecular Weight	289.369
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	CACTVS	3.385	CN1[CH]2CC[CH]1C[CH](C2)OC(=O)[CH](CO)c3ccccc3
SMILES	OpenEye OEToolkits	2.0.7	CN1C2CCC1CC(C2)OC(=O)C(CO)c3ccccc3
Canonical SMILES	CACTVS	3.385	CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(=O)[C@H](CO)c3ccccc3
Canonical SMILES	OpenEye OEToolkits	2.0.7	CN1[C@@H]2CC[C@H]1CC(C2)OC(=O)[C@H](CO)c3ccccc3
InChI	InChI	1.03	InChI=1S/C17H23NO3/c1-18-13-7-8-14(18)10-15(9-13)21-17(20)16(11-19)12-5-3-2-4-6-12/h2-6,13-16,19H,7-11H2,1H3/t13-,14+,15+,16-/m1/s1
InChIKey	InChI	1.03	RKUNBYITZUJHSG-FXUDXRNXSA-N

Drug Info: DrugBank

DrugBank ID	DB00424
Name	Hyoscyamine
Groups	approved
Description	Hyoscyamine is a tropane alkaloid and the levo-isomer of [atropine].[A228423] It is commonly extracted from plants in the _Solanaceae_ or nightshade family.[A228423] Research into the action of hyoscyamine in published literature dates back to 1826.[A228713] Hyoscyamine is used for a wide variety of treatments and therapeutics due to its antimuscarinic properties.[L31548,L31553] Although hyoscyamine is marketed in the United States, it is not FDA approved.[L31548,L31553]
Synonyms	L-Hyoscyamine (S)-atropine (−)-hyoscyamine Hyoscyamine sulfate dihydrate [3(S)-endo]-α-(hydroxymethyl)benzeneacetic acid 8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester Hyoscyamine Hyoscyamine sulfate (S)-(−)-hyoscyamine Daturin Duboisine Hyoscyaminum Hyoscyamine hydrobromide Hyoscyamin Tropine-L-tropate (−)-atropine Daturine L-Tropine tropate
Brand Names	Donnagel Liq Hyosyne Hyoscyamine Sulfate TAB Ustell Donnatal Extentabs Hyophen Uramit Mb Hyoscyamine sulfate Sublingual Re-PB Hyos Elixir Azuphen Mb Uro-BLUE Hyoscyamine Sulfate Sublingual Se-donna Pb Hyos Hyolev Mb Donnatal Extentabs Srt Phenobarbital, Hyoscyamine Sulfate, Atropine Sulfate and Scopolamine Hydrobromide Pyrelle H.B. Phenobarbital With Belladonna Alkaloids Urophen Mb Uro-458 Phenobarbital with Belladonna Alkaloids - Grape Ed-spaz Hyoscyamine Phosphasal Phenazopyridine Hydrochloride, Hyoscyamine Hydrobromide, and Butabarbital Hyoscyamine Sulfate SL Symax SR UroAv-81 Uretron D/S Phosenamine Uro-L Quadrapax NuLev Me NaPhos MB Hyo 1 Donnatal Tab Symax SL Uralgic Hyoscyamine sulfate Re-PB Hyos Phenohytro Belladonna Alkaloids with Phenobarbital Urimar-T Uribel Hyoscyamine ER Me-PB-Hyos Phenobarbital with Belladonna Alkaloids Anaspaz Prosed/DS PB Hyos Phenobarbital, Hyoscyamine Sulfate, Atropine Sulfate, Scopolamine Hydrobromide Oscimin Urolet Mb Calmitol Itching Relief Ont Uta Donnatal Elixir HyoMax Levsin Drops 0.125mg/ml Hyoscyamine Sulfate ODT Hyoscyamine SL Servira UR N-C Urinary Antiseptic Donnatal Hyoscyamine S L UroAv-B Hyoscyamine Sulfate Extended-Release Vilevev MB Urin D/S Hyoscyamine Sulfate Sl Vilamit MB Uro-SP Methylphen B-Donna Symax Duotab Hyoscyamine Sulfate Drops Diban Cap Symax FasTab Levsin SL UrNeva HyoMax-DT Indiomin Mb HyoMax-SL Uribel Tabs Urogesic Blue Levbid Utira-C Uro-MP HyoMax-FT Hyoscyamine Sulfate Levsin HyoMax-SR Urised Vitetal Phenazopyridine Plus Urimar-T Caps Belladonna Alkaloids with Phenobartbital Darcalma Phenobarbital with Belladonna Alkaloids - Mint Darpaz Urelle
Indication	As a drug that is not FDA approved, hyscyamine has no official indications.[L31548,L31553] Intravenous hysocyamine has been used to reduce gastric motility, reduce pancreatic pain and secretions, to facilitate imaging of the gastrointestinal tract, treat anticholinesterase toxicity, treat certain cases of partial heart block, improve visualization of the kidneys, and for symptomatic relief of biliary and renal colic.[L31548] Intravenous hyoscyamine is also used pre-operatively to reduce secretions of the mouth and respiratory tract to facilitate intubation.[L31548] Oral hyoscyamine is used to treat functional intestinal disorders, for symptomatic relief of biliary and renal colic, and symptomatic relief of acute rhinitis.[L31553]
Categories	Adjuvants, Anesthesia Agents producing tachycardia Alimentary Tract and Metabolism Alkaloids Anti-Asthmatic Agents Antiarrhythmic agents Anticholinergic Agents Atropine Derivatives Autonomic Agents Aza Compounds Azabicyclo Compounds Belladonna Alkaloids Belladonna Alkaloids, Tertiary Amines Belladonna and Derivatives, Plain Bronchodilator Agents Cardiovascular Agents Central Nervous System Agents Cholinergic Agents Drugs for Functional Gastrointestinal Disorders Muscarinic Antagonists Mydriatics Neurotransmitter Agents Parasympatholytics Peripheral Nervous System Agents Potential QTc-Prolonging Agents QTc Prolonging Agents Respiratory System Agents Solanaceous Alkaloids Tropanes
ATC-Code	A03BA03 A03CB31
CAS number	101-31-5

Drug Targets

Name	Target Sequence	Pharmacological Action	Actions
Muscarinic acetylcholine receptor M1	MNTSAPPAVSPNITVLAPGKGPWQVAFIGITTGLLSLATVTGNLLVLISF...	unknown	antagonist
Muscarinic acetylcholine receptor M5	MEGDSYHNATTVNGTPVNHQPLERHRLWEVITIAAVTAVVSLITIVGNVL...	unknown	antagonist
Muscarinic acetylcholine receptor M2	MNNSTNSSNNSLALTSPYKTFEVVFIVLVAGSLSLVTIIGNILVMVSIKV...	unknown	antagonist
Muscarinic acetylcholine receptor M3	MTLHNNSTTSPLFPNISSSWIHSPSDAGLPPGTVTHFGSYNVSRAAGNFS...	unknown	antagonist
Muscarinic acetylcholine receptor M4	MANFTPVNGSSGNQSVRLVTSSSHNRYETVEMVFIATVTGSLSLVTVVGN...	unknown	antagonist
Adenylate cyclase type 1	MAGAPRGGGGGGGGAGEPGGAERAAGTSRRRGLRACDEEFACPELEALFR...	unknown	inhibitor
View More

Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682